Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
종목 코드 ALUR
회사 이름Allurion Technologies Inc
상장일Mar 29, 2021
CEODr. Shantanu Gaur, M.D.
직원 수134
유형Ordinary Share
회계 연도 종료Mar 29
주소11 Huron Dr Ste 200
도시NATICK
증권 거래소NYSE Consolidated
국가United States of America
우편 번호01760
전화15086474000
웹사이트https://www.allurion.com/en
종목 코드 ALUR
상장일Mar 29, 2021
CEODr. Shantanu Gaur, M.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음